Farmoten

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Farmoten

What is Farmoten?

Farmoten is a pharmaceutical medication containing the active substance captopril. It belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. This medication is primarily used to manage conditions affecting the cardiovascular system by interacting with specific biological pathways that regulate blood pressure and fluid balance.

Mechanism of Action

Farmoten works by inhibiting the activity of the enzyme responsible for converting angiotensin I into angiotensin II. Angiotensin II is a potent natural substance in the body that causes blood vessels to narrow and stimulates the release of hormones that retain salt and water. By reducing the production of angiotensin II, Farmoten facilitates the following physiological effects:

  • Vasodilation: The blood vessels relax and widen, which helps to lower blood pressure.
  • Reduced Workload: The heart does not have to pump as hard to circulate blood through the body.
  • Improved Blood Flow: Enhanced circulation helps support the function of vital organs, particularly the kidneys and the heart.

Clinical Applications

Farmoten is utilized in various clinical scenarios related to heart and circulatory health. Its primary applications include:

  • Hypertension: It is used to manage high blood pressure, either alone or in combination with other types of medication.
  • Heart Failure: It may be used to assist in the management of chronic heart failure, often alongside diuretics and digitalis.
  • Post-Myocardial Infarction: Following a heart attack, it is sometimes used to improve survival rates and reduce the risk of further heart complications by preventing the heart muscle from undergoing unfavorable structural changes.
  • Diabetic Nephropathy: It is used to manage kidney disease in patients with type 1 diabetes, as it can help slow the progression of kidney damage.

What side effects are possible with Farmoten?

The official safety profile of Farmoten (Captopril) is defined by categories of adverse reactions documented in government regulatory sources, classified by frequency and affected body systems.

Adverse Reaction Scope

Category Regulatory Description
Common (1–10%) A persistent, non-productive cough; changes in or loss of taste (dysgeusia); dizziness; rash; and mild gastrointestinal symptoms like nausea or diarrhea are commonly reported.
Uncommon (0.1–1%) Angioedema (swelling of the face, lips, tongue, or extremities); tachycardia (rapid heart rate); chest pain; and symptomatic hypotension (low blood pressure).
Serious Adverse Reactions The most critical reactions highlighted in official labels include potentially fatal angioedema (laryngeal swelling), severe blood disorders such as neutropenia/agranulocytosis, and acute renal failure.

Safety Constraints and Considerations

Safety notes specify that Farmoten must not be used in individuals with a history of angioedema related to a previous ACE inhibitor treatment. Furthermore, regulatory guidelines explicitly contraindicate its use with neprilysin inhibitors (e.g., sacubitril) or within 36 hours of switching to/from this class due to increased risk of angioedema.

The official label includes warnings regarding use during the second and third trimesters of pregnancy due to the risk of fetal injury and death. Hypotension risk is often highest following the initial dose or during dose escalation, particularly in patients who are volume-depleted.

Connection to the Overall Safety Profile

This structured regulatory information establishes a clear framework that identifies both frequent, non-serious effects and rare, critical risks like angioedema and severe blood disorders. By classifying reactions by system and frequency, the official documentation defines the full spectrum of possible effects and the strict conditions under which the medication is restricted from use.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Farmoten (Captopril) is documented in regulatory labeling as an emergency scenario primarily characterized by severe hypotension (excessively low blood pressure) which may progress to shock and lethargy or stupor. Other documented clinical manifestations include bradycardia (slow heart rate), electrolyte disturbances, and the potential for renal failure as a serious outcome. These severe haemodynamic effects can elevate the risk for secondary complications such as myocardial infarction or stroke in susceptible individuals.

Immediate regulatory guidance mandates that you seek emergency medical attention right away if an overdose is suspected or has occurred. Immediately call emergency services if the individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. Treatment is supportive, as no specific antidote is known.

Official management procedures include placing the patient in a supine position and administering rapid volume repletion with salt and fluid supplements to counter hypotension. Procedures such as haemodialysis are described as methods to potentially remove Captopril from the body's circulation. Specialized considerations are noted for infants, who are documented as being more vulnerable to prolonged decreases in blood pressure, potentially resulting in oliguria and seizures.

Therapeutic Uses of Farmoten

Farmoten is a commonly used medication applied to manage chronic, systemic cardiovascular and renal conditions, contributing to supportive management against progressive organ damage and symptoms related to systemic imbalance. The medication’s core therapeutic applications focus on three key domains of patient care.


Therapeutic Applications

The primary application is for the chronic treatment of high blood pressure (hypertension), generally helping with managing blood pressure levels. It is also relevant in the management of congestive heart failure and is used for clinically stable patients who have recently had a heart attack. It is also relevant for patients with Type 1 insulin-dependent diabetes and established kidney involvement. In these contexts, Farmoten is applied to address symptom clusters that may become intense or disruptive, such as breathlessness and fluid retention associated with chronic heart failure. This contributes to a practical benefit that may assist with easing the impact of symptoms on routine activities.

“The medication is generally applied in contexts where additional symptomatic support is needed to ease the overall burden of chronic systemic conditions.”

Quick Fact: Support for Systemic Imbalance

Farmoten is commonly used to help with conditions marked by increased physiological stress, assisting with maintaining functional stability when symptoms interfere with routine activities.


Clinical Support and Benefit

For patients requiring long-term treatment, Farmoten may help in the management of cardiovascular risks of experiencing major events. Furthermore, for those with diabetic nephropathy, the medication supports the management of progressive renal functional stress, generally helping to support renal functional stability in the long term. This provides supportive relief when symptoms interfere with routine activities and contributes to easing the overall symptom load.

Eligibility and Restrictions for Use

This information is strictly based on official government regulatory documents for Captopril (the active ingredient in Farmoten) and defines who is eligible to use the medicine and who is prohibited.

Contraindicated Populations (Must Not Use)

  • Patients with a history of angioedema (severe swelling) related to previous treatment with any Angiotensin-Converting Enzyme (ACE) inhibitor.
  • Patients with known hypersensitivity or allergy to captopril or any other ACE inhibitor.
  • Pregnant women in the second and third trimesters, as use carries a risk of injury and death to the fetus. The drug should be discontinued as soon as pregnancy is detected.
  • Patients with diabetes receiving the drug aliskiren.
  • Patients receiving a neprilysin inhibitor (e.g., sacubitril) or within 36 hours of switching to or from such a medicine.

Restricted or Conditional Use Groups

  • Pediatric population: Safety and efficacy have not been established.
  • Patients with impaired renal function or collagen vascular disease (e.g., lupus) with kidney disease: Use is restricted due to an increased risk of severe blood or kidney problems, and is often reserved for those who have failed other therapies.
  • Breastfeeding women: Captopril is excreted in human milk, and a decision must be made to discontinue either nursing or the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Farmoten (Captopril) interactions are documented in regulatory labeling based on their effects on blood pressure regulation, electrolyte balance, and substance clearance.

Mandatory Prohibitions and Restrictions

Co-administration with Sacubitril/Valsartan is strictly contraindicated. A mandatory 36-hour separation period is required when switching to or from this medication due to the documented risk of severe swelling (Angioedema). The combination of Captopril and Aliskiren is contraindicated for patients with diabetes and should be avoided in patients with moderate to severe renal impairment.

Pharmacodynamic Effects

There is an officially documented risk of Hyperkalemia (elevated serum potassium) when Farmoten is combined with potassium-sparing diuretics or potassium supplements/salt substitutes. The simultaneous use of other medicines that also block the Renin-Angiotensin System, such as Angiotensin Receptor Blockers (ARBs), results in increased risks of hypotension and renal changes. Co-administration with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) may reduce blood pressure control and increase the risk to kidney function. The risk of severe blood disorders, including neutropenia, is officially heightened when taken with agents like Allopurinol or Procainamide.

Specific Substance Exposure and Timing

Captopril reduces the clearance of Lithium, which officially leads to increased serum lithium concentrations and the risk of toxicity. Furthermore, due to an absorption-altering interaction documented in regulatory information, Farmoten should be administered one hour before a meal.

Mechanism of Action

Farmoten (enalapril maleate) is a pro-drug that undergoes rapid hydrolysis in the liver, yielding its active metabolite, enalaprilat. Enalaprilat acts as a competitive inhibitor of the angiotensin-converting enzyme (ACE), which is the primary biological target within the renin-angiotensin-aldosterone system (RAAS).

Inhibiting ACE prevents the enzymatic conversion of the inactive precursor, angiotensin I, into the vasoconstrictor angiotensin II. This pathway modulation results in a decrease in the concentration of circulating angiotensin II. The resulting mechanistic cascade reduces the activation of AT1 receptors on vascular smooth muscle, leading to diminished systemic vasoconstriction.

Simultaneously, ACE inhibition prevents the rapid degradation of the vasodilator bradykinin. The combined effect of reduced vasoconstriction, diminished aldosterone secretion, and increased bradykinin activity constitutes the system-level physiological consequence of modulating vascular tone and fluid balance.

Dosage and Administration Information

Farmoten is administered exclusively via the oral route using the tablet formulation. The official dosing protocol requires the total daily quantity to be divided and taken typically two or three times a day (BID or TID). The specific starting dose varies based on the condition being addressed, with regimens like 25 mg three times daily used for hypertension, and lower initial quantities like 6.25 mg two or three times daily used for heart failure.


Administration Timing and Schedule

A critical instruction for proper use involves the timing of administration relative to food. The tablets must be taken on an empty stomach, specifically one hour before meals, as food significantly impairs the absorption of the active ingredient. Treatment is generally intended as a long-term management protocol for chronic conditions. When adjusting the daily quantity, it is established that dose increases should be implemented cautiously at intervals of at least two weeks to allow for the full assessment of therapeutic response. The maximum daily quantity permitted across all indications is 450 mg.


Population-Specific Dosing Rules

The standardized regimen is subject to modification based on the patient's profile. Treatment for older adults generally requires initiation with a lower starting dose, such as 6.25 mg twice daily. Furthermore, patients with documented renal impairment necessitate a significant reduction in the daily quantity and/or a decrease in the frequency of administration, as defined by the severity of the kidney functional stress. In the event of a missed administration, the standard protocol is to skip the missed quantity if it is near the time for the next scheduled dose, and never to double the dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Farmoten

This section provides an objective overview of the clinical research and study structures that support the understanding of Farmoten (Captopril), adhering only to evidence found in authoritative regulatory and scientific sources.


Evidence for the Management of High Blood Pressure (Hypertension)

Clinical research exploring Farmoten for high blood pressure (hypertension) includes short-term and long-term Randomized Controlled Trials (RCTs) and observational studies. These primarily examine outcomes related to changes in systolic and diastolic blood pressure in adults, including those with severe elevations. Long-term cohort data show patterns related to sustained changes observed in blood pressure levels. Research has noted differences in blood pressure measurements observed in some non-White patient populations.

Evidence for the Treatment of Heart Failure and Post-Heart Attack Support

The research framework for cardiovascular support is based on large-scale, placebo-controlled RCTs. These trials were designed to assess long-term outcomes, tracking the incidence of all-cause and cardiovascular mortality, hospitalization frequency, and changes in physical capacity measures. Studies often involved clinically stable adults following a heart attack with reduced heart function, but strict entry criteria generally led to the exclusion of individuals with acute or highly unstable conditions.

Evidence for Managing Diabetic Kidney Involvement

Research dedicated to the drug's use in patients with Type 1 diabetes who have kidney involvement (diabetic nephropathy) consists of dedicated placebo-controlled trials. These studies monitored outcomes such as the time to the occurrence of specific renal events, including the doubling of serum creatinine and progression to end-stage renal disease (ESRD). Trials reported measurements of the progression rate of kidney function over the study period. The extent to which these findings are entirely independent of the concurrent blood pressure status remains a complex question in the research.


Long-Term Studies and What is Still Uncertain About the Research

The research landscape related to long-term outcomes primarily involves follow-up periods ranging up to 4 years in key trials. Limited information is available regarding outcomes that extend beyond these defined intervals. The results apply only to the specific populations studied, and data for certain subgroups, such as children, remain limited. The overall evidence landscape indicates areas where more research is ongoing.

Frequently Asked Questions (FAQ)

Common questions about Farmoten (FAQ)


Q: Can I take Farmoten with vitamins or mineral supplements?

Official regulatory warnings focus primarily on the use of potassium supplements or salt substitutes because of a documented risk of causing high blood potassium levels (hyperkalemia). Product information does not typically list warnings for common multivitamin supplements, but the product information may not contain warnings for all specialty supplements.


Q: Is Farmoten okay to use if I have kidney problems?

According to official warnings, Farmoten (Captopril) is used with caution in individuals with impaired renal (kidney) function. Regulatory documents indicate that these patients often require a significantly reduced starting dose and slow, careful dose adjustments, as there is an increased risk of severe kidney problems. The determination of appropriate use is a matter for individual patient assessment by a healthcare professional.


Q: Does Farmoten have any impact on mental alertness?

Regulatory documents state that the medicine can cause common side effects such as dizziness, lightheadedness, and/or fatigue (tiredness). Side effects such as dizziness or low blood pressure are relevant factors for activities requiring mental alertness.


Q: Are there official recommendations regarding driving while taking Farmoten?

Warnings regarding operating hazardous machinery or driving are included in official patient information. This is based on the potential for side effects like dizziness, lightheadedness, or feeling faint due to low blood pressure, especially when starting the medication or adjusting the quantity.


Q: Is there a generic version of Farmoten?

Yes, the active ingredient in Farmoten, which is Captopril, is available as a generic formulation. Government drug registers confirm the availability of generic versions in many markets worldwide.


Q: How long does it typically take for people to notice the effects of Farmoten?

Official product information indicates that the full therapeutic effect of the medicine often requires consistent dosing over a period of time. For this reason, dose adjustments are typically made at intervals of at least two weeks to allow for a full assessment of how the medicine is working.


Q: Are headaches a frequent side effect reported by Farmoten users?

Yes, headaches are listed in regulatory documents among the reported side effects for Farmoten (Captopril). They are categorized in some official documentation as a common adverse reaction.


Q: Is it normal to feel tired when starting Farmoten?

Fatigue, or unusual tiredness, is listed as a potential side effect in official regulatory documents. This effect is described as occurring in some patients.


Q: Are there any interactions mentioned between Farmoten and alcohol?

Regulatory sources describe that alcohol (ethanol) can have an additive effect in lowering blood pressure when taken with this medicine. This effect may increase the risk of symptoms related to low blood pressure, such as dizziness or feeling lightheaded.


Q: Can people with liver conditions use Farmoten?

Official warnings note that the medicine is generally used with caution in patients who have liver disease. This is because these conditions may increase the risk of certain side effects.


Q: What does 'contraindicated' mean in the context of Farmoten?

In medical terms, a contraindication is a specific medical condition or situation (such as a known allergy or pregnancy) where a drug is generally restricted from use. For Farmoten, official documents list conditions like pregnancy in the second and third trimesters as contraindications because the potential harm is greater than the benefit.


Q: Does Farmoten have a risk of dependence or addiction?

Regulatory documents do not list dependence or addiction as known risks associated with Farmoten (Captopril) use. Furthermore, the medicine is not classified as a controlled substance under federal drug laws.


Q: Is Farmoten considered a controlled substance?

No, the active ingredient Captopril is not classified as a controlled substance by regulatory authorities.


Q: What is the 'half-life' of Farmoten?

The half-life refers to the time it takes for half of the medicine to be eliminated from the bloodstream. According to official clinical pharmacology data for Captopril, the elimination half-life is approximately 1.9 to 3 hours.


Q: How is Farmoten eliminated from the body?

Official product information states that Farmoten (Captopril) is primarily excreted from the body via the kidneys (renal route). It is excreted partly unchanged and partly metabolized through the urine.


Q: Is Farmoten still being studied for its main use?

Regulatory documentation indicates that research on the use and outcomes of the medicine is ongoing. This research often focuses on specific populations, long-term effects, or patient subgroups.


Q: Is there a risk of withdrawal symptoms if Farmoten is stopped suddenly?

Official patient information indicates that discontinuation of the medicine should occur under professional medical guidance. This general instruction points to a risk associated with abruptly stopping treatment for chronic conditions, though specific 'withdrawal symptoms' are not itemized.


Q: If I stop taking Farmoten, what might happen?

Abrupt cessation of the medication, particularly for chronic conditions like high blood pressure, is associated with a possible return or worsening of the condition being managed. This is a general caution noted in official patient information.


Q: Is the medication designed to be swallowed whole or can it be broken?

Specialist pharmacy services and patient leaflets indicate that Captopril tablets can generally be crushed and/or dispersed in water or mixed with a small amount of soft food. When the tablet is altered for administration, official information indicates it is intended to be taken immediately.


Q: Does Farmoten have any known effect on fertility?

Official documents contain well-documented warnings and risks concerning fetal toxicity during the second and third trimesters of pregnancy. However, regulatory sources do not explicitly detail known effects on general male or female fertility.


Q: How is the safety of Farmoten monitored after it has been approved?

The safety of the medicine is continuously monitored through a process called post-marketing surveillance. This is where regulatory agencies, like the FDA, collect reports of any new or serious adverse reactions from patients and healthcare professionals.


Q: Is Farmoten available in different strengths?

Yes, official product information confirms that Captopril is available in multiple oral tablet strengths, typically including 12.5 mg, 25 mg, 50 mg, and 100 mg.


Q: Does Farmoten have a Black Box Warning from the FDA?

Yes, the product carries a Black Box Warning (a boxed warning), which is the most serious warning required by the FDA. This warning concerns the risk of fetal injury or death if the medicine is taken during the second or third trimesters of pregnancy.


Q: What should I do if I experience an unexpected reaction to Farmoten?

The onset of serious symptoms, such as swelling of the face, lips, tongue, or throat (angioedema), is described in official documentation as requiring the individual to immediately contact a healthcare professional. These types of reactions necessitate urgent medical attention.

How should Farmoten be stored and disposed of?

Official Storage and Disposal Requirements

Storage and disposal instructions for Farmoten (captopril) are strictly defined by regulatory authorities to maintain drug stability and ensure safety.

Storage Conditions
Temperature: Store at room temperature; do not store above 30 C (86 F) or allow the medication to freeze.
Protection: Protect the medicine from heat, moisture, and direct light.
Container: Keep the medicine in a closed container with the bottles tightly closed; do not use the product if the bottle seal is not intact.

For safety, this medication must be kept out of the reach of children at all times.

To dispose of Farmoten, regulatory guidance states that you should ask a healthcare professional how to properly dispose of any unused or no longer needed medicine. Do not flush or place it in household trash unless specifically instructed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Farmoten found in:

A-Z Index: